Is Johnson & Johnson a Good Stock to Buy?
Johnson & Johnson (NYSE:JNJ) currently trades at 23 times trailing earnings, which we’d normally consider to be a bit high for a stable consumer health and healthcare company...
Posts Tagged ‘Pfizer Inc (PFE)’
5 Cheap Dividend Stocks for Prudent Investors
Value investors buy stocks of companies that appear to be priced below their intrinsic values based on financial metrics such as price-to-earnings ratios, price-to-book ratios...
Why Merck & Co., Inc. (MRK) Is Still A Top Notch Drug Company
Merck & Co., Inc. (NYSE:MRK) was down over 5% following disapproval of its latest cholesterol-related drug.
The 10 Biggest Cash Generators on the S&P 500
It takes a buck to make a buck. That's true for individual investors and the corporate giants in the S&P 500 alike.
Google Inc (GOOG), Intel Corporation (INTC) and 3 Other Big Bets from Paul Tudor Jones
Paul Tudor Jones founded Tudor Investment in 1980 and has amassed a personal net worth of over $3 billion since.
Ken Fisher & Jim Simons: Two Billionaires Bulking Up On Drugs
Billionaires Ken Fisher and Jim Simons are two of the top names in the money management business.
Viking Global’s Dividend Stock Picks
Andreas Halvorsen is the Chief Investment Officer of Viking Global Investors, a $17-billion fundamentals-oriented long/short global equity fund.
Billionaire Ken Fisher Thinks Pfizer Is Right For You
Billionaire Ken Fisher isn’t only the head of Fisher Asset Management, but also a long-running Forbes columnist whose picks published in that magazine have tended to outperform...
5 Dividend Picks From Billionaire Stanley Druckenmiller
Stanley Druckenmiller founded Duquesne Capital in 1981, but closed his fund in 2010.
Pfizer, Johnson & Johnson, Merck: 10 Pharma Stocks Hedge Funds Love
After identifying the ten most popular stocks among hedge funds according to their third quarter 13F filings, we have decided to break down the top ten stocks that hedge funds...
Hedge Fund News: David Einhorn, Steven Cohen, Citigroup Inc.
Greenlight Capital Re Ltd., the reinsurer that counts hedge-fund manager David Einhorn as its chairman, rose the most since August as UBS AG raised its rating on the firm to buy...
$5 Billion Hedge Fund’s 5 Dividend Stocks
PointState Capital is a money management firm with some $5 billion in assets under management.
Billionaire Israel Englander is Behaving Quite Bullishly
Billionaire Israel Englander was making an overall bullish statement with equity purchases in 3Q, shaking up his top twenty holdings with various increases and new additions across...
These 3 Stocks Could be Tomorrow’s High-Yielders
Dividend-growth stocks can do wonders for an investor's portfolio over time.
Molson Coors shares fizzle after earnings amid down-day for stocks
Molson Coors Brewing Company (NYSE:TAP) – Shares in the beer brewing company are on the decline today, joining the broad-based sell-off in equities as investors re-focus attention...
George Soros’ 7 Favorite Dividend Stock Picks
George Soros is the founder and chairman of hedge fund Soros Fund Management LLC.
Kahn Brothers’ Top Stock Picks For Q3
Irving and Thomas Kahn are value investors who have been running their investment firm since 1978.
11 Stocks With More Impressive Margins than Apple Inc (AAPL)
During the past five years, engineers at Apple Inc.
Hedge Fund News: GLG Partners, Man Group, George Soros
You could not blame GLG Partners co-founder Noam Gottesman for feeling a little smug today.
Hedge Fund News: Marc Faber, Carl Icahn, BlackRock
America’s central bank, the Federal Reserve, will eventually destroy the world economy, says respected Swiss investor Marc Faber.
Arena Pharma (ARNA), Vivus (VVUS): Which Hedge Funds Made the Wrong Pharma Bets?
Since the end of 2Q, the very popular biopharma companies, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA), Questcor Pharmaceuticals, Inc. (NASDAQ:QCOR) and Vivus, Inc.
3 High-Yield Pharma Stocks With Major Catalysts
Income investors can find attractive high-yields in the pharmaceutical sector right now. Many major drug makers, including familiar names like Merck & Co., Inc.
Walgreen: How It Plans on Realizing $1 BIllion in Synergies
In my last article on Walgreen Company (NYSE:WAG), I gave light on pressing issues revolving around the world’s largest drugstore.
Is Pfizer a Good Stock to Buy?
Pfizer Inc. (NYSE:PFE) is up 5% over the last month and is now making a push towards a $200 billion market capitalization.
Bain Capital’s Bet Against Romney
As debate season heats up, we had an interesting takeaway from the first 2012 Presidential debate yesterday.
Will Its Addition to the Dow Benefit UnitedHealth?
Health insurance provider UnitedHealth Group Inc. (NYSE:UNH) will become its sector's first representative in the prestigious Dow Jones Industrial Average.
Hedge Fund News: Kodak, Louis Bacon, George Soros
A New York hedge fund that owns bonds of bankrupt Eastman Kodak has asked the US Trustee to probe the company's patent auction because it was concerned about the "unusually secretive...
Hedge Fund News: Prudential, Jim Rogers, George Soros
Prudential Financial has hired a hedge fund economist to boost its emerging markets credit capabilities.
Hedge Fund News: Pfizer, General Motors, Paul Tudor Jones
Pfizer (PFE) Inc., Johnson & Johnson (JNJ) and Elan Corp.
Samuel Isaly Reported Changes in His Third Quarter Holdings
Samuel Isaly reported his amended 13F portfolio on November 23rd. He made a lot of changes to his original third quarter 13F which was filed a few days ago.
Hedge Funds Sell Pharmaceuticals, Financial Stocks in 3rd Quarter
Some of the biggest names in the hedge fund industry revamped their portfolios in the third quarter.
Cramer on $CELG, Berkowitz Report, Hedge Fund Redemptions
Jim Cramer is the host of the popular “Mad Money” show on CNBC. He is famous for making big bold calls, liking momentum stocks and preferring dividend yielding stocks.
Greenlight Capital Has Positive YTD 2011 Returns $PFE $GDX $STX
David Einhorn's Greenlight Capital was finally getting some breaks this year. During the third quarter the stocks he has been shorting went down 20%.
David Einhorn Thinks Gold Companies Will Outperform Bullion
David Einhorn, Greenlight Capital has noticed a "substantial disconnect" in the market according to Bloomberg and he is investing accordingly. (more…)
Billionaire George Soros’ High Dividend Stock Picks
Billionaire George Soros returned an average of around 30% per year in his career. That's how he became a billionaire.
Top of the Morning – New Plan for Underwater Borrowers
Troubled Franco-Belgian bank Dexia SA said Tuesday it expects to conclude plans for the Belgian state to take control of its Dexia Bank Belgium unit at a board meeting scheduled...
20 High Dividend Stocks That Analysts Recommend
Defensive investors like high dividend yielding stocks and consider them as viable options especially in inflationary environments.
12 Most Popular Healthcare Stocks Among Hedge Funds
Insider Monkey follows hedge fund managers because they're the smartest investors around. They leave less to chance than do most investors.
Hedge Funds’ Favorite High Dividend Stocks $PFE $SNY $BP $MRK $INTC $VOD
We like dividend stocks and consider them a better alternative than the 10-year treasuries. We think it just doesn't make sense to invest in 10-year or longer treasuries.
10 Most Popular Stocks Among Hedge Funds
Insider Monkey tracks more than 300 hedge funds and a few mutual funds with very respectable track records like Bruce Berkowitz’s Fairholme.
Is Ray Dalio Running A Ponzi Scheme? $TSO $PFE $LII
Is Ray Dalio running a Ponzi Scheme? The title of this article may be a little hyperbolic but it is a fact that the performance of Ray Dalio's stock picks doesn't match the reported...
High Dividend Dow Stocks
Investors are concerned about a Lehman-like collapse in Europe and are spooked by the S&P’s downgrade of America’s credit rating.
Intriguing Similarities Between Curtis Macnguyen and David Einhorn’s Portfolios
Curtis Macnguyen started Ivory Capital in 1998 after working at Siegler, Collery & Co. He returned 11.8% annually after fees between 1998 and early 2009, vs.
Glenview Capital Management’s Top Stock Picks
Larry Robbins’ Glenview Capital Management returned 82.7% in 2009 after losing 50% in 2008.
Hedge Funds Love These High Dividend Stocks $PM $PFE $JNJ
In times of uncertainty, investors look to high-dividend paying stocks for some sort of normalcy.
10 Most Popular Stocks Among Hedge Funds. Apple Isn’t Number One!
Insider Monkey tracks more than 300 hedge funds and a few mutual funds with very respectable track records like Bruce Berkowitz's Fairholme.
Hedge Funds’ Favorite Healthcare Stocks
In this article we will be reporting about hedge fund's favorite heathcare stocks.
Lee Ainslie and Maverick Capital’s Extremely Bullish Stock Picks
Lee Ainslie’s Maverick Capital was extremely bullish about Hewlett-Packard during the third quarter. They bet $400 Million on HPQ, making it the second biggest position in ...
David Einhorn and Greenlight Capital’s New Stock Purchases
David Einhorn’s Greenlight Capital returned 15.9% in 2010, and 21.5% since its inception in 1996. It is one of the hedge funds we follow very closely.
